Oslo, Norway

Marit Mellemseter

This inventor holds 1 USPTO granted patent. Top assignee: Respinor as. Active years: 2025.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marit Mellemseter: Innovator in Acoustic Technology

Introduction

Marit Mellemseter is a notable inventor based in Oslo, Norway. She has made significant contributions to the field of acoustic technology, particularly with her innovative designs and methods.

Latest Patents

Mellemseter holds a patent for an acoustic coupling device and method of using the device. This device includes a base tape member with a hole, featuring a sensor side and a skin side, each equipped with an adhesive material. Additionally, the device incorporates a tray that is removably attached to cover the skin side of the base tape member. The tray has an indentation that defines a concave face facing the hole, along with a flat portion surrounding the indentation. Furthermore, the device contains ultrasound transferring gel disposed in the indentation, and a removable protective liner that covers the sensor side of the base tape member. This innovative design enhances the effectiveness of acoustic coupling in various applications.

Career Highlights

Mellemseter is currently employed at Respinor AS, where she continues to develop her ideas and contribute to advancements in acoustic technology. Her work has garnered attention for its practical applications and innovative approach.

Collaborations

Throughout her career, Mellemseter has collaborated with talented individuals such as David Gerez and Jessica Thomasson. These partnerships have allowed her to expand her research and enhance the impact of her inventions.

Conclusion

Marit Mellemseter is a pioneering inventor whose work in acoustic technology is making waves in the industry. Her innovative acoustic coupling device exemplifies her commitment to advancing technology for practical use.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…